Myunghee Kim Selected Research

Immunotherapy

3/2021

Monophosphoryl lipid A-induced activation of plasmacytoid dendritic cells enhances the anti-cancer effects of anti-PD-L1 antibodies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Myunghee Kim Research Topics

Disease

4	Neoplasms (Cancer) 07/2023 - 01/2017
4	Inflammation (Inflammations) 01/2023 - 03/2021
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 02/2023
1	Infertility (Sterility) 01/2023
1	Experimental Melanoma 03/2021
1	Poisoning 03/2020
1	Dengue (Dengue Fever) 01/2018
1	Vector Borne Diseases 01/2018
1	Malaria 01/2018
1	Filariasis 01/2018

Drug/Important Bio-Agent (IBA)

1	Programmed Cell Death 1 ReceptorIBA 07/2023
1	Androgen Receptors (Androgen Receptor)IBA 02/2023
1	MycotoxinsIBA 01/2023
1	Vitamin E FDA LinkGeneric 04/2022
1	N-acetyldopamineIBA 01/2022
1	LipopolysaccharidesIBA 01/2022
1	Cathepsin CIBA 01/2022
1	AntibodiesIBA 03/2021
1	Toll-Like Receptor 4IBA 03/2021
1	LigandsIBA 03/2021
1	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 03/2021
1	monophosphoryl lipid AIBA 03/2021
1	Immune Checkpoint InhibitorsIBA 03/2021
1	Indicators and Reagents (Reagents)IBA 03/2020
1	Histamine (Histamine Dihydrochloride)FDA Link 03/2020
1	InsecticidesIBA 01/2018
1	AflatoxinsIBA 01/2017

Therapy/Procedure

1	Immunotherapy 03/2021